Peptides may serve adjunctive roles by reducing inflammation (KPV, Selank), supporting nerve repair during and after immune-mediated damage (BPC-157, TB-500), and providing neurotrophic support (Semax, GHK-Cu)
\n\n\n\n Unlike many pharmacological interventions studied for tendon repair, BPC-157 does not appear to interfere with the natural inflammatory response in ways that inhibit healing
Here are the most common recommendations: The sweet spot for most peptides and most protocols is a concentration that allows you to draw between 5 and 30 units per dose
But, its important to learn how from a healthcare provider
Locally, BPC 157 reduces swelling and tissue damage where injury and inflammation occur
Precursor recycling (e.g., NR, NMN) also wanes due to reduced enzyme efficiency in salvage pathways